COURT-RULING ·Filed Mar 30, 2026

REGN

Regeneron
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

Monitor for future docket updates or public filings in this case. Given the lack of accessible information, no immediate trading action is warranted. Be cautious of potential information asymmetry if material details emerge later.

DirectionNeutral
Confidencelow
Horizonweeks
Final — all horizons settled through T+60d
REGN ▼ -16.51% at T+60d
NEUTRAL call ✗ call lost -16.51% · α vs SPY -32.54% · entry $746.75 → $623.43
Entry anchored
Mar 27, 03:59 PM ET
via exchange tick
T+1d
+3.12%
call +3.12% · α +0.23%
$770.08
settled 6mo ago
T+5d
+1.75%
call +1.75% · α -2.55%
$759.81
settled 6mo ago
T+20d
-2.33%
call -2.33% · α -14.93%
$729.36
settled 5mo ago
T+60d
-16.51%
call -16.51% · α -32.54%
$623.43
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The case 'Fraioli v. Regeneron Pharmaceuticals, Inc.' was filed in the Southern District of Florida, but no substantive ruling or opinion text is accessible to assess the outcome, financial exposure, or business impact.

Court Ruling Details

Court
United States District Court for the Southern District of Florida
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • Case: Fraioli v. Regeneron Pharmaceuticals, Inc. et al, filed 2026-03-30 in the Southern District of Florida (Case No. 1:26-cv-20636)
  • No ruling text or docket entries available — only a login redirect for PACER system
  • Plaintiff is Fraioli; Regeneron is named as defendant
  • Nature of suit or claims cannot be determined from available data

Financial Impact

Unknown — no information on damages, injunctions, or settlement

Risk Factors

  • Potential for material undisclosed litigation risk if the case involves securities, product liability, or regulatory claims
  • Low visibility increases uncertainty, which could lead to volatility if details are later disclosed

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-iczfz1rr-REGN
26 reports for REGN
Performance horizon
85% Hit rate 11 of 13 directional calls best @ T+60▲ +26.47%May 21, 2026
Filters
Rows
Reports for REGN — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
—awaiting T+5——
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$843.47 $781.49▼ −7.35%▼ −6.20%$735.20 (−12.84%)
Aug 24, 2026
5w ago
Court Ruling
BULLISH ★ 5/10
$828.50 $799.08▼ −3.55%▼ −4.02%$735.20 (−11.26%)
Aug 20, 2026
6w ago
Press Release
NEUTRAL ★ 5/10
$826.64 $807.71▼ −2.29%▼ −3.40%$735.20 (−11.06%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$797.99 $840.84▲ +5.37%▲ +5.81%$735.20 (−7.87%)
Aug 11, 2026
7w ago
Court Ruling
BULLISH ★ 5/10
$797.00 $807.57▲ +1.33%▲ +1.73%$735.20 (−7.75%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$738.34 $772.11▲ +4.57%▲ +0.95%$735.20 (−0.43%)
Jul 30, 2026
9w ago
Press Release
BULLISH ★ 7/10
$738.34 $772.11▲ +4.57%▲ +0.95%$735.20 (−0.43%)
Jul 27, 2026
9w ago
Press Release
BEARISH ★ 6/10
$695.18 $759.24▼ −9.21%▼ −6.95%$735.20 (−5.76%)
Jul 17, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$676.69 $651.91▼ −3.66%▼ −2.97%$735.20 (+8.65%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (65h 6m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access